Urokinase for injection is a thrombolytic drug, mainly used for
thrombolytic therapy of thromboembolic diseases, and it is a kind of urgent
rescue drug in short supply.
Urokinase is extracted from urine, so why is it facing a shortage? Through
investigations and interviews with the relevant person in charge of Jiudong
Technology, a crude urokinase supplier that has been cooperating with domestic
and foreign pharmaceutical companies for many years, we learned that: it seems
that it is very common in daily life Urine is actually a scarce resource. With
the improvement of living standards, people's requirements for the environment
are getting higher and higher, and the places where urine is allowed to be
collected are decreasing day by day. For public toilets, the utilization rate of
most of them is declining day by day, and the urine is becoming more and more
scattered. As for schools, the main collection places, there are now more and
more independent toilets in dormitory buildings and fewer and fewer public
toilets. The difficulty of collecting urine is increasing.
The rise in the price of urokinase for injection has given confidence and
encouragement to the urokinase extraction industry, and the urokinase industry
has ushered in new benefits. In fact, the difficulty of urokinase extraction
technology is not high. Compared with other industries, the investment threshold
is not high. For those who want to start a business or prepare to start a
business, the urokinase extraction industry is a good choice.